MATR3 and prostate cancer: SNHG1 is reported to bind to certain RBPs like heterogeneous nuclear ribonucleoprotein L (HNRNPL) and matrin 3 (MATR3) and to promote the progression of prostate cancer (PCa) as well as neuroblastoma (58, 59).